Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-09

FDA Approved: NEFFY — Original Application (ARS Pharmaceuticals Operations, Inc.)

View source ↗

Summary

The FDA approved NEFFY (epinephrine) from ARS Pharmaceuticals in an original application for the treatment of anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEFFY (epinephrine)

Snippet

ORIG AP for NEFFY (EPINEPHRINE)